Sisodia Yashi, Shah Komal, Ali Sayyed Adil, Jain Meenakshi, Ali Syed Ansar, Gondaliya Piyush, Kalia Kiran, Tekade Rakesh Kumar
Department of Biotechnology, National of Pharmaceutical Education and Research, Ahmedabad, Gujarat, 382355, India.
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, Gujarat, 382355, India.
Biomater Sci. 2023 Jan 31;11(3):777-790. doi: 10.1039/d2bm00951j.
Respiratory diseases account for unprecedented mortality owing to a lack of personalized or insufficient therapeutic interventions. Fostering pulmonary research into managing pulmonary threat requires a potential alternative approach that can mimick the complexities of the human body. The miniaturized bionic simulation of the lung holds great potential in the quest for a successful therapeutic intervention. This review discusses the emerging roles of lung-on-chip microfluidic simulator devices in fostering translational pulmonary drug discovery and personalized medicine. This review also explicates how the lung-on-chip model emulates the breathing patterns, elasticity, and vascularization of lungs in creating a 3D pulmonary microenvironment.
由于缺乏个性化或治疗干预不足,呼吸系统疾病导致了前所未有的死亡率。促进肺部研究以应对肺部威胁需要一种潜在的替代方法,该方法能够模拟人体的复杂性。肺的小型化仿生模拟在寻求成功的治疗干预方面具有巨大潜力。本文综述了芯片肺微流控模拟装置在促进转化性肺部药物发现和个性化医疗方面的新兴作用。本文还阐述了芯片肺模型如何在创建三维肺部微环境时模拟肺的呼吸模式、弹性和血管生成。